U.S. FDA Approves Update to the Label for WINREVAIR to Include Data from the Phase 3 HYPERION Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension 6h
Merck Canada Partners with the Montreal Museum of Fine Arts to Present the North American Premiere of Chiharu Shiota: The Soul Trembles 21 September
Merck's KEYTRUDA QLEX Approved in Japan for Subcutaneous Administration for All KEYTRUDA® Indications Approved in Japan 21 September
